東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/01/07 | 1,935 | 1,942 | 1,901 | 1,904 | -9 | -0.5% | 87,900 |
2021/01/06 | 1,882 | 1,918 | 1,880 | 1,913 | +31 | +1.6% | 80,100 |
2021/01/05 | 1,879 | 1,896 | 1,874 | 1,882 | -12 | -0.6% | 92,400 |
2021/01/04 | 1,928 | 1,936 | 1,885 | 1,894 | -20 | -1% | 54,000 |
2020/12/30 | 1,955 | 1,955 | 1,914 | 1,914 | -49 | -2.5% | 70,000 |
2020/12/29 | 1,926 | 1,966 | 1,921 | 1,963 | +41 | +2.1% | 107,800 |
2020/12/28 | 1,918 | 1,943 | 1,910 | 1,922 | +4 | +0.2% | 105,700 |
2020/12/25 | 1,911 | 1,918 | 1,891 | 1,918 | +23 | +1.2% | 83,300 |
2020/12/24 | 1,878 | 1,895 | 1,868 | 1,895 | +22 | +1.2% | 75,600 |
2020/12/23 | 1,870 | 1,885 | 1,858 | 1,873 | +3 | +0.2% | 69,200 |
2020/12/22 | 1,864 | 1,876 | 1,848 | 1,870 | -14 | -0.7% | 101,900 |
2020/12/21 | 1,869 | 1,886 | 1,862 | 1,884 | +15 | +0.8% | 86,800 |
2020/12/18 | 1,850 | 1,869 | 1,845 | 1,869 | +20 | +1.1% | 122,000 |
2020/12/17 | 1,893 | 1,893 | 1,846 | 1,849 | -31 | -1.6% | 112,900 |
2020/12/16 | 1,886 | 1,897 | 1,873 | 1,880 | +6 | +0.3% | 75,100 |
2020/12/15 | 1,879 | 1,902 | 1,873 | 1,874 | -14 | -0.7% | 82,400 |
2020/12/14 | 1,884 | 1,904 | 1,872 | 1,888 | +4 | +0.2% | 68,000 |
2020/12/11 | 1,866 | 1,884 | 1,854 | 1,884 | +15 | +0.8% | 76,700 |
2020/12/10 | 1,892 | 1,892 | 1,865 | 1,869 | -25 | -1.3% | 68,600 |
2020/12/09 | 1,885 | 1,894 | 1,871 | 1,894 | +18 | +1% | 57,600 |
2020/12/08 | 1,863 | 1,877 | 1,851 | 1,876 | +14 | +0.8% | 89,100 |
2020/12/07 | 1,880 | 1,880 | 1,855 | 1,862 | -24 | -1.3% | 107,800 |
2020/12/04 | 1,892 | 1,894 | 1,873 | 1,886 | -1 | -0.1% | 101,600 |
2020/12/03 | 1,889 | 1,894 | 1,864 | 1,887 | +4 | +0.2% | 119,200 |
2020/12/02 | 1,900 | 1,900 | 1,874 | 1,883 | -17 | -0.9% | 156,000 |
2020/12/01 | 1,926 | 1,926 | 1,892 | 1,900 | -1 | -0.1% | 88,300 |
2020/11/30 | 1,935 | 1,940 | 1,897 | 1,901 | -34 | -1.8% | 166,100 |
2020/11/27 | 1,920 | 1,935 | 1,899 | 1,935 | +38 | +2% | 261,100 |
2020/11/26 | 1,890 | 1,912 | 1,872 | 1,897 | +3 | +0.2% | 108,100 |
2020/11/25 | 1,934 | 1,934 | 1,894 | 1,894 | -1 | -0.1% | 102,400 |
2020/11/24 | 1,928 | 1,939 | 1,892 | 1,895 | +3 | +0.2% | 140,500 |
2020/11/20 | 1,884 | 1,903 | 1,863 | 1,892 | +23 | +1.2% | 98,200 |
2020/11/19 | 1,901 | 1,905 | 1,863 | 1,869 | -35 | -1.8% | 154,800 |
2020/11/18 | 1,922 | 1,927 | 1,896 | 1,904 | -19 | -1% | 112,000 |
2020/11/17 | 1,941 | 1,942 | 1,901 | 1,923 | -29 | -1.5% | 125,900 |
2020/11/16 | 1,928 | 1,975 | 1,882 | 1,952 | -5 | -0.3% | 214,100 |
2020/11/13 | 2,022 | 2,022 | 1,937 | 1,957 | -61 | -3% | 124,300 |
2020/11/12 | 2,025 | 2,026 | 2,002 | 2,018 | -5 | -0.2% | 78,000 |
2020/11/11 | 2,057 | 2,062 | 2,007 | 2,023 | ±0 | ±0% | 111,400 |
2020/11/10 | 2,061 | 2,070 | 2,016 | 2,023 | -19 | -0.9% | 150,100 |
2020/11/09 | 2,061 | 2,064 | 1,983 | 2,042 | -10 | -0.5% | 135,400 |
2020/11/06 | 2,022 | 2,059 | 2,003 | 2,052 | +16 | +0.8% | 92,800 |
2020/11/05 | 1,991 | 2,039 | 1,985 | 2,036 | +67 | +3.4% | 115,100 |
2020/11/04 | 1,998 | 1,998 | 1,957 | 1,969 | +11 | +0.6% | 121,800 |
2020/11/02 | 1,929 | 1,974 | 1,929 | 1,958 | +29 | +1.5% | 69,600 |
2020/10/30 | 1,963 | 1,963 | 1,919 | 1,929 | -40 | -2% | 98,600 |
2020/10/29 | 1,952 | 1,992 | 1,951 | 1,969 | +5 | +0.3% | 83,000 |
2020/10/28 | 1,968 | 1,974 | 1,950 | 1,964 | -23 | -1.2% | 88,300 |
2020/10/27 | 1,971 | 1,988 | 1,939 | 1,987 | +6 | +0.3% | 106,400 |
2020/10/26 | 1,983 | 2,000 | 1,962 | 1,981 | +1 | +0.1% | 63,200 |
951~
1000
件表示中 / 6839件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 282,000円 | +15.0% | -7.3% | 2.13% | 9.25倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
科研薬 | 446,100円 | +22.8% | +113.0% | 4.26% | 11.90倍 | 1.09倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 365,500円 | +14.5% | -2.3% | 2.46% | 13.37倍 | 0.71倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム